Outsourced Pharma Capacity Update Videos - Cell & Gene

  1. Resilience Capacity Update May 2024: Cell & Gene Therapy 6/13/2024

    With a strong network of 11 sites located across North America supporting 5 modalities, Resilience provides innovative solutions and services for established and emerging therapies.

  2. ReciBioPharm Capacity Update May 2024: Cell & Gene Therapy 6/13/2024

    Learn more about our global capabilities in Nucleic Acid, AAV, Lentivirus, Microbiome and Fill-Finish. We offer end-to-end GMP manufacturing under one roof through an integrated supply chain.

  3. Vernal Biosciences Capacity Update May 2024: Cell & Gene Therapy 6/13/2024

    Examine our platform analytical and process technologies designed to accelerate the development of your cell therapy, gene therapy, or vaccine drug product.

  4. Aldevron Capacity Update May 2024: Cell & Gene Therapy 6/13/2024

    Explore the new capacity and capabilities of our complete mRNA Ecosystem to offer streamlined services for process development, manufacture, and release of both mRNA drug substance and product.

  5. MilliporeSigma Capacity Update May 2024: Cell & Gene Therapy 6/13/2024

    Discover how we apply our 30 years of experience to enhance quality and de-risk viral vector production at any stage and knowhow to advance cell and gene therapies from pre-IND through routine supply.

  6. Comprehensive Cell Solutions Capacity Update May 2024: Cell & Gene Therapy 6/13/2024

    Comprehensive Cell Solutions is a CGT focused division of New York Blood Center Enterprises with a Draw-To-Thaw™ portfolio of CDMO services strategically located throughout the US built upon on NYBC’s 60+ years of experience.

  7. WuXi Advanced Therapies Capacity Update May 2024: Cell & Gene Therapy 6/13/2024

    Review an update on our 400,000+ square foot campus in Philadelphia, Pennsylvania and the infrastructure dedicated to Cell & Gene Therapy development, testing and manufacturing.

  8. Pfizer CentreOne Capacity Update May 2024: Cell & Gene Therapy 6/13/2024

    Review Pfizer CentreOne’s overall gene & cell therapy capabilities, with a focus on their ability to help meet your complex viral vector needs.

  9. Andelyn Biosciences Capacity Update May 2024: Cell & Gene Therapy 6/13/2024

    Learn how our proven methodology and decades-long AAV database at the core of the AAV Curator™ Platform directly drives speed, maximizes yields, and delivers a high-quality product.

  10. Theragent Capacity Update May 2024: Cell & Gene Therapy 6/13/2024

    Gain insight into our proprietary digital platform that de-risks clinical trials, expedites manufacturing, offers full transparency to sponsors, and provides complete chain-of-custody assurance.